JPY 2001.0
(-0.2%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | -60.59 Million | 2.5 Billion | 2.03 Billion | 4.29 Billion | 805 Million |
Net Income | 2.37 Billion | 3.05 Billion | 2.8 Billion | 1.9 Billion | 694 Million |
Depreciation & Amortization | 546.4 Million | 480.51 Million | 566.29 Million | 518.26 Million | 594 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -2.2 Billion | -984.94 Million | -772.17 Million | 2.63 Billion | 317 Million |
Other non-cash items | -214.19 Million | 122.87 Million | -6.17 Million | -284.03 Million | -800 Million |
Investing Cash Flow | 982.47 Million | -2.45 Billion | -1.87 Billion | -1.01 Billion | 56 Million |
Investments in PPE | -1.62 Billion | -1.81 Billion | -1.48 Billion | -361.25 Million | -178 Million |
Acquisitions | 1.82 Million | 6.14 Million | 1.49 Million | 1.28 Million | 388 Thousand |
Investment purchases | -61.96 Million | -665.99 Million | -282.03 Million | -729.67 Million | -251.04 Million |
Sales/Maturities of investments | 2.63 Billion | 100.05 Million | 26.56 Million | 107.3 Million | 332.69 Million |
Other Investing Activities | 2.55 Billion | -166.41 Million | -45.59 Million | -84.61 Million | 234 Million |
Financing Cash Flow | 253.49 Million | 183.08 Million | 883.41 Million | 1.18 Billion | 347 Million |
Debt repayment | -498.04 Million | -427.5 Million | -1.12 Billion | -1.32 Billion | -465 Million |
Dividends payments | -244.25 Million | -244.14 Million | -243.82 Million | -146.18 Million | -138.59 Million |
Common Stock Repurchased | -288 Thousand | -274 Thousand | -283 Thousand | -289 Thousand | -269 Thousand |
Common Stock Issuance | - | - | 23 Thousand | - | 952.2 Million |
Other Financing Activities | -2000.00 | -1000.00 | -2000.00 | -2000.00 | 950 Million |
Accounts receivables | -1.66 Billion | -455 Million | -39 Million | 1.4 Billion | 269 Million |
Accounts payables | 914.35 Million | 61.34 Million | 597.77 Million | -286.67 Million | -1.46 Billion |
Inventory | -1.27 Billion | -499.47 Million | -668.77 Million | 1.6 Billion | -239 Million |
Other working capital | 12 Million | 120 Million | -277 Million | -108 Million | 287 Million |
Cash at beginning of period | 15.55 Billion | 15.31 Billion | 14.27 Billion | 9.81 Billion | 8.6 Billion |
Cash at end of period | 16.73 Billion | 15.55 Billion | 15.31 Billion | 14.27 Billion | 1.2 Billion |
Capital Expenditure | -1.62 Billion | -1.81 Billion | -1.48 Billion | -361.25 Million | -178 Million |
Effect of forex changes on cash | 5.91 Million | 4.86 Million | 5.1 Million | 822 Thousand | - |
Net cash flow / Change in cash | 1.18 Billion | 238.41 Million | 1.04 Billion | 4.45 Billion | -7.4 Billion |
Free Cash Flow | -1.68 Billion | 685.32 Million | 549.54 Million | 3.93 Billion | 627 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 521 Million | 329 Million | 2.37 Billion | 503 Million | 248 Million | 554 Million |
Depreciation & Amortization | - | - | 546.4 Million | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -2.2 Billion | - | - | - |
Other non-cash items | -521 Million | -329 Million | -214.19 Million | -503 Million | -248 Million | -554 Million |
Investing Cash Flow | - | - | 982.47 Million | - | - | - |
Investments in PPE | - | - | -1.62 Billion | - | - | - |
Acquisitions | - | - | 1.82 Million | - | - | - |
Investment purchases | - | - | -61.96 Million | - | - | - |
Sales/Maturities of investments | - | - | 2.63 Billion | - | - | - |
Other Investing Activities | - | - | 2.55 Billion | - | - | - |
Financing Cash Flow | - | - | 253.49 Million | - | - | - |
Debt repayment | - | - | -498.04 Million | - | - | - |
Dividends payments | - | - | -244.25 Million | - | - | - |
Common Stock Repurchased | - | - | -288 Thousand | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -2000.00 | - | - | - |
Accounts receivables | - | - | -1.66 Billion | - | - | - |
Accounts payables | - | - | 914.35 Million | - | - | - |
Inventory | - | - | -1.27 Billion | - | - | - |
Other working capital | - | - | 12 Million | - | - | - |
Cash at beginning of period | - | - | 15.55 Billion | - | - | - |
Cash at end of period | - | - | 16.73 Billion | - | - | - |
Capital Expenditure | - | - | -1.62 Billion | - | - | - |
Effect of forex changes on cash | - | - | 5.91 Million | - | - | - |
Net cash flow / Change in cash | - | - | 1.18 Billion | - | - | - |
Free Cash Flow | - | - | -1.68 Billion | - | - | - |
PROTEAN
2107
CRDO
CIIHY
AFT
GENUSPOWER